review article | Q7318358 |
meta-analysis | Q815382 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/14651858.CD005212.PUB2 |
P698 | PubMed publication ID | 17054248 |
P50 | author | Brigid E Hickey | Q57612791 |
Helen Margot Lehman | Q79281435 | ||
P2093 | author name string | D Francis | |
P2860 | cites work | Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials | Q29031162 |
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials | Q29547513 | ||
Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review | Q35057465 | ||
Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. | Q35757885 | ||
The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial | Q35994659 | ||
Sequential audits of unacceptable delays in radiation therapy in Australia and New Zealand. | Q38462761 | ||
A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma | Q40522396 | ||
Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery | Q40598907 | ||
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial | Q40603092 | ||
Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution study | Q40997619 | ||
Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel | Q43816485 | ||
Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen | Q44124154 | ||
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer | Q44230659 | ||
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. | Q44362100 | ||
Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study | Q44433155 | ||
The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study | Q44513225 | ||
Radiation and concomitant chemotherapy after surgery for breast cancer | Q44848789 | ||
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial | Q45229101 | ||
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial | Q46387542 | ||
Adjuvant docetaxel for node-positive breast cancer | Q46522790 | ||
A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer | Q46754343 | ||
Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study | Q47597305 | ||
Odd man out: a graphical approach to meta-analysis. | Q52558328 | ||
Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group. | Q52888114 | ||
A comparison of delays in the treatment of cancer with radiation in Canada and the United States. | Q53375552 | ||
Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer | Q58229285 | ||
Combined sequential approach in locally advanced breast cancer | Q63184914 | ||
A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trial. | Q64917780 | ||
Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome | Q67948177 | ||
The second ten years: long-term risks of breast conservation in early breast cancer | Q70355478 | ||
Effect of delay in radiation in the combined modality treatment of breast cancer | Q70681524 | ||
The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer | Q70709089 | ||
Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control? | Q70790897 | ||
Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence | Q71067095 | ||
Combined chemotherapy and radiotherapy for locally advanced breast cancer | Q71182652 | ||
Effect of delayed radiation therapy on local control in breast conservation therapy | Q71395736 | ||
How Should We Manage Breast Cancer in the Breast, or Buddy, Can You Paradigm? | Q72038539 | ||
Waiting for radiotherapy in Ontario | Q72181317 | ||
Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer | Q72531101 | ||
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy | Q73374269 | ||
[Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer] | Q74334425 | ||
CMF + radiotherapy in the primary treatment of operable breast cancer: preliminary results of a phase II pilot study | Q74608030 | ||
The sequencing of radiation therapy and chemotherapy after mastectomy in premenopausal women with breast cancer | Q75230848 | ||
[Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study ] | Q77734730 | ||
Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer | Q78222751 | ||
P433 | issue | 4 | |
P921 | main subject | chemotherapy | Q974135 |
adaptive radiation therapy | Q180507 | ||
P304 | page(s) | CD005212 | |
P577 | publication date | 2006-10-18 | |
P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
P1476 | title | Sequencing of chemotherapy and radiation therapy for early breast cancer |
Q37657782 | Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012. |
Q60050114 | Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Adva |
Q35583779 | Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider |
Q33330481 | Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy - a retrospective analysis |
Q50146461 | Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients |
Q35749321 | Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells |
Q87460937 | Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institution |
Search more.